We hypothesised that N-terminal brain natriuretic peptide (NT-proBNP) would be activated in MR and, because this is a validated diagnostic test in heart failure, it could prove to be an early marker for the development of left ventricular (LV) dysfunction. The gene discussed is NPPB; the disease is miotic rate.